AMERICAN SHARED HOSPITAL SERVICES Shareholders' Equity
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Shareholders' Equity of $23.11 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $23.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $23.52M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $24.03M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $24.57M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $23.11M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $23.52M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $24.03M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $24.57M 10-Q/A · filed 2026-01-16 |
| 2025-06-30 | $24.48M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $24.65M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $25.18M 10-K · filed 2026-03-31 |
| 2024-09-30 | $26.42M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $26.54M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $22.84M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $22.62M 10-K · filed 2025-04-04 |
| 2023-09-30 | $22.11M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $21.89M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $21.91M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $21.63M 10-K · filed 2024-04-01 |
| 2022-09-30 | $21.21M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $20.82M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $20.25M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $19.89M 10-K · filed 2023-03-31 |
| 2021-09-30 | $19.57M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $19.42M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $19.41M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $19.27M 10-K · filed 2022-03-30 |
| 2020-09-30 | $25.39M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $25.52M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $25.95M 10-Q/A · filed 2020-06-11 |
| 2019-12-31 | $26.03M 10-K · filed 2021-04-06 |
| 2019-09-30 | $25.78M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $25.51M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $25.43M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $25.10M 10-K · filed 2020-04-03 |
| 2018-09-30 | $24.87M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $24.64M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $24.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $23.86M 10-K · filed 2019-03-29 |
| 2017-09-30 | $22.27M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $22.12M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $21.95M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $21.50M 10-K · filed 2018-03-28 |
| 2016-09-30 | $20.77M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $20.39M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $20.24M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $20.13M 10-K · filed 2017-03-27 |
| 2015-09-30 | $19.78M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $19.68M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $21.59M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $21.43M 10-K · filed 2016-03-30 |
| 2014-09-30 | $20.68M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $20.66M 10-Q · filed 2014-08-15 |
| 2014-03-31 | $19.55M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $19.62M 10-K · filed 2015-04-01 |
| 2013-09-30 | $19.63M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $19.82M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $20.00M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $19.93M 10-K · filed 2014-03-31 |
| 2012-09-30 | $20.20M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $20.26M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $20.24M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $20.20M 10-K · filed 2013-03-29 |
| 2011-09-30 | $19.93M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $19.69M 10-Q/A · filed 2011-10-24 |
| 2010-12-31 | $19.57M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |